Accelerated Atherosclerosis in Rheumatoid Arthritis: Rationale for Mannose-binding Lectins?

REFERENCES

1. 1.↵
   1. Harris ED,
   2. Budd RC,
   3. Firestein GS,
   4. Genovese MC,
   5. Sergent JS,
   6. Ruddy S,
   7. et al.

   1. Harris ED

   . Clinical features of rheumatoid arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, et al., editors. Kelley’s textbook of rheumatology. 7th ed. Philadelphia: Elsevier Saunders; 2005:1243–78.
2. 2.↵
   1. Turesson C,
   2. O’Fallon WM,
   3. Crowson CS,
   4. Gabriel SE,
   5. Matteson EL

   . Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62–7.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Van Doornum S,
   2. McColl G,
   3. Wicks IP

   . Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862–73.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Pinals RS

   . Survival in rheumatoid arthritis. Arthritis Rheum 1987;30:473–5.

   OpenUrlPubMed
5. 5.↵
   1. Vandenbroucke JP,
   2. Hazevoet HM,
   3. Cats A

   . Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol 1984;11:158–61.

   OpenUrlPubMed
6. 6.↵
   1. Reilly PA,
   2. Cosh JA,
   3. Maddison PJ,
   4. Rasker JJ,
   5. Silman AJ

   . Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990;49:363–9.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Naz SM,
   2. Symmons DP

   . Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871–83.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Symmons DP,
   2. Jones MA,
   3. Scott DL,
   4. Prior P

   . Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072–7.

   OpenUrlPubMed
9. 9.↵
   1. Goodson NJ,
   2. Wiles NJ,
   3. Lunt M,
   4. Barrett EM,
   5. Silman AJ,
   6. Symmons DP

   . Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002;46:2010–9.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Martin J

    . Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8–17.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Szekanecz Z,
    2. Kerekes G,
    3. Dér H,
    4. Sándor Z,
    5. Szabó Z,
    6. Végvári A,
    7. et al.

    Accelerated atherosclerosis in rheumatoid arthritis. Ann NY Acad Sci 2007;1108:349–58.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Wolfe F,
    2. Freundlich B,
    3. Straus WL

    . Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36–40.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Maradit-Kremers H,
    2. Nicola PJ,
    3. Crowson CS,
    4. Ballman KV,
    5. Gabriel SE

    . Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722–32.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Shoenfeld Y,
    2. Gerli R,
    3. Doria A,
    4. Matsuura E,
    5. Cerinic MM,
    6. Ronda N,
    7. et al.

    Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337–47.

    OpenUrlFREE Full Text
15. 15.↵
    1. Kaplan MJ

    . Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2006;18:289–97.

    OpenUrlPubMed
16. 16.↵
    1. Snow MH,
    2. Mikuls TR

    . Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 2005;17:234–41.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Ross R

    . Atherosclerosis — an inflammatory disease. N Engl J Med 1999;340:115–26.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Watson DJ,
    2. Rhodes T,
    3. Guess HA

    . All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003;30:1196–202.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Solomon DH,
    2. Karlson EW,
    3. Rimm EB,
    4. Cannuscio CC,
    5. Mandl LA,
    6. Manson JE,
    7. et al.

    Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Chung CP,
    2. Oeser A,
    3. Avalos I,
    4. Gebretsadik T,
    5. Shintani A,
    6. Raggi P,
    7. et al.

    Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006;8:R186.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Solomon DH,
    2. Curhan GC,
    3. Rimm EB,
    4. Cannuscio CC,
    5. Karlson EW

    . Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004;50:3444–9.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Gonzalez-Juanatey C,
    2. Llorca J,
    3. Testa A,
    4. Revuelta J,
    5. Garcia-Porrua C,
    6. Gonzalez-Gay MA

    . Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003;82:407–13.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. del Rincon ID,
    2. Williams K,
    3. Stern MP,
    4. Freeman GL,
    5. Escalante A

    . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737–45.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Rho YH,
    2. Chung CP,
    3. Oeser A,
    4. Solus J,
    5. Asanuma Y,
    6. Sokka T,
    7. et al.

    Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009;61:1580–5.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Ip WK,
    2. Takahashi K,
    3. Ezekowitz RA,
    4. Stuart LM

    . Mannose-binding lectin and innate immunity. Immunol Rev 2009;230:9–21.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Garred P,
    2. Larsen F,
    3. Madsen HO,
    4. Koch C

    . Mannose-binding lectin deficiency — revisited. Mol Immunol 2003;40:73–84.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Graudal NA,
    2. Madsen HO,
    3. Tarp U,
    4. Svejgaard A,
    5. Jurik G,
    6. Graudal HK,
    7. et al.

    The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000;43:515–21.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Jacobsen S,
    2. Madsen HO,
    3. Klarlund M,
    4. Jensen T,
    5. Skjødt H,
    6. Jensen KE,
    7. et al.,
    8. TIRA Group

    . The influence of mannose-binding lectin polymorphisms on disease outcome in patients with early polyarthritis. J Rheumatol 2001;28:935–42.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Barton A,
    2. Platt H,
    3. Salway F,
    4. Symmons D,
    5. Lunt M,
    6. Worthington J,
    7. et al.

    Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid arthritis or inflammatory polyarthritis. J Rheumatol 2004;31:442–7.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Jacobsen S,
    2. Garred P,
    3. Madsen HO,
    4. Heegaard NH,
    5. Hetland ML,
    6. Stengaard-Pedersen K,
    7. et al.

    Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 2009; 36:731–5.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Troelsen LN,
    2. Garred P,
    3. Jacobsen S

    . Mortality and predictors of mortality in rheumatoid arthritis — A role for mannose-binding lectin? J Rheumatol 2010;37:536–43.

    OpenUrlAbstract/FREE Full Text